Le Lézard
Classified in: Health, Science and technology
Subject: NEW PRODUCTS/SERVICES

Ibogaine By David Dardashti To Explore Glial Cells Through EEG With Computer Tomography


MIAMI, March 04, 2024 (GLOBE NEWSWIRE) -- The Ibogaine By David Dardashti clinic is embarking on an ambitious initiative to advance knowledge and understanding of glial cells and their effect on the brain.

Unlocking Brain Healing

Ibogaine By David Dardashti hopes to advance ibogaine research, with major projects involving a cross-analytical approach of EEG with computer tomography. The clinic hopes to analyze glial cell production through images of brain growth. The goal of the program is to obtain data over a select number of individuals before and after ibogaine treatment. By using EEG and computer tomography, the Ibogaine By David Dardashti clinic will be able to detect any difference in glial cell production after treatment.

This not only could prove the benefits of ibogaine as a recovery supplement, it would also prove ground-breaking in the study of electrodynamics involving brain activity and their involvement in the production of glial cells. David Dardashti, founder of the Ibogaine By David Dardashti clinic, comments, "We are extremely excited about the potential this project could bring to the field of ibogaine healing and electrodynamic understanding of glial cell production in the brain. This could be a major turning point in ibogaine therapy, with greater understanding of how ibogaine affects the brain in real time."

The Ibogaine By David Dardashti clinic is utilizing EEG and computer tomography to measure changes in brain growth and glial cell production with the goal of gaining greater understanding of ibogaine healing and electrodynamic understanding of the brain.

If you are interested in contributing to this dynamic project, or if you would like to find out more information about Ibogaine by David Dardashti , please visit our website at www.ibogaineclinic.com



These press releases may also interest you

at 09:05
Pheast Therapeutics ("Pheast"), a biotech developing novel macrophage checkpoint therapies to defy cancer, today announced the first presentation of preclinical data for PHST001, an anti-CD24 antibody drug candidate that is designed to block a key...

at 09:03
BabyBuddha, an innovator in creating the portable breast pump that makes mom's breastfeeding journey easier and lighter, announces the launch of its new pump, the BabyBuddha 2.0 Breast Pump. The BabyBuddha 2.0 is a versatile powerhouse that grows...

at 09:00
Empatica, a pioneer in digital biomarker development and patient monitoring driven by AI, and McRoberts, one of the leaders in ambulatory monitoring of physical activity, announce the integration of all 71 McRoberts endpoints in Empatica's digital...

at 09:00
Following Chinaplas last month, SK chemicals plans to expand the global market by introducing technology that leads the circular recycling industry in North America." SK chemicals (CEO Jae-hyun Ahn) participated in NPE 2024 (NPE 2024:...

at 09:00
Muse Health, LLC, a recognized leader in BIPOC healthcare services, today announced a strategic partnership with Welcome Tech, a technology and services platform that accelerates success for immigrant households. Through comprehensive engagement and...

at 09:00
WAT Medical, a leader in innovative healthcare solutions, announces the development of ObeEnd, the world's first weight management wristband backed by clinical evidence showcasing its efficacy in reducing dietary intake. Findings from this...



News published on and distributed by: